This is an extremely unfortunate situation, however, in the United States, it is not a novel occurrence. Approximately a third of cancer patients drop out of treatment plans because of costs. Treatment for cancer is expensive, and, despite insurance coverage, deductibles remain high. Many patients are unable to continue working and subsequently also lose their employment-based health insurance. Without a job to pay bills, support a family or save for the future, receiving chemotherapy causes insurmountable emotional and financial distress. Even years after diagnosis, cancer survivors have higher medical costs compared to those who do not carry such a diagnosis. Therefore cancer patients are three times more likely to file for bankruptcy, and by stopping treatment, they risk the worsening of the disease. The term "financial toxicity" has been coined to encompass this dilemma.